ARCA biopharma

$6.43
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.35 (5.76%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell ARCA biopharma and other stocks, options, ETFs, and crypto commission-free!

About ABIO

ARCA biopharma, Inc. Common Stock, also called ARCA biopharma, is a biopharmaceutical company, which develops genetically targeted therapies for heart failure and other cardiovascular diseases. Read More The company engages in cardiovascular pathophysiology, molecular genetics and clinical development. Its product candidate, GencaroTM is a pharmacologic beta-blocker and mild vasodilator, which is developed for the treatment of chronic heart failure and other indications. The company was founded by Michael R. Bristow and Christopher David Ozeroff in 1992 and is headquartered in Westminster, CO.

Employees
15
Headquarters
Westminster, Colorado
Founded
1992
Market Cap
6.69M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
300.07K
High Today
$6.47
Low Today
$6.02
Open Price
$6.06
Volume
55.46K
52 Week High
$20.45
52 Week Low
$4.73

Collections

ABIO Earnings

-$1.98
-$1.35
-$0.73
-$0.10
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Nov 13, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.